MASM, a Matrine Derivative, Offers Radioprotection by Modulating Lethal Total-Body Irradiation-Induced Multiple Signaling Pathways in Wistar Rats.
MASM, a Matrine Derivative, Offers Radioprotection by Modulating Lethal Total-Body Irradiation-Induced Multiple Signaling Pathways in Wistar Rats.
复制标题
MASM 是一种苦参碱衍生物,通过调节 Wistar 大鼠致死性全身辐射诱导的多信号通路提供辐射防护
DOI:
10.3390/molecules21050649
复制
发表时间:
2016-05-17
期刊:
影响因子:
--
通讯作者:
Zhang J
中科院分区:
文献类型:
--
作者:
Li J;Xu J;Lu Y;Qiu L;Xu W;Lu B;Hu Z;Chu Z;Chai Y;Zhang J
Matrine is an alkaloid extracted from Sophora flavescens Ait and has many biological activities, such as anti-inflammatory, antitumor, anti-fibrosis, and immunosuppressive properties. In our previous studies, the matrine derivative MASM was synthesized and exhibited potent inhibitory activity against liver fibrosis. In this study, we mainly investigated its protection against lethal total-body irradiation (TBI) in rats. Administration of MASM reduced the radiation sickness characteristics and increased the 30-day survival of rats before or after lethal TBI. Ultrastructural observation illustrated that pretreatment of rats with MASM significantly attenuated the TBI-induced morphological changes in the different organs of irradiated rats. Gene expression profiles revealed that pretreatment with MASM had a dramatic effect on gene expression changes caused by TBI. Pretreatment with MASM prevented differential expression of 53% (765 genes) of 1445 differentially expressed genes induced by TBI. Pathway enrichment analysis indicated that these genes were mainly involved in a total of 21 pathways, such as metabolic pathways, pathways in cancer, and mitogen-activated protein kinase (MAPK) pathways. Our data indicated that pretreatment of rats with MASM modulated these pathways induced by TBI, suggesting that the pretreatment with MASM might provide the protective effects on lethal TBI mainly or partially through the modulation of these pathways, such as multiple MAPK pathways. Therefore, MASM has the potential to be used as an effective therapeutic or radioprotective agent to minimize irradiation damages and in combination with radiotherapy to improve the efficacy of cancer therapy.
登录
查看更多内容
影响因子:
3.7
作者:
Fukumoto R;Burns TM;Kiang JG
通讯作者:
Kiang JG
影响因子:
11.2
作者:
Gauger, MA;Sancar, A
通讯作者:
Sancar, A
DOI:
10.1111/j.1365-2613.2006.00480.x
发表时间:
2006-06-01
影响因子:
3
作者:
Hussein, Mahmoud R.;Abu-Dief, Eman E.;Abdelraheem, Mohamad H.
通讯作者:
Abdelraheem, Mohamad H.
影响因子:
5.4
作者:
Chappell, James;Dalton, Stephen
通讯作者:
Dalton, Stephen
影响因子:
3.4
作者:
Johnston, CJ;Williams, JP;Finkelstein, JN
通讯作者:
Finkelstein, JN